Pieris Pharmaceuticals Inc (NAS:PIRS)
$ 10.2 0.05 (0.49%) Market Cap: 13.47 Mil Enterprise Value: -12.97 Mil PE Ratio: 0 PB Ratio: 0.57 GF Score: 46/100

Q3 2019 Pieris Pharmaceuticals Inc Earnings Call Transcript

Nov 11, 2019 / 01:00PM GMT
Release Date Price: $316 (+1.28%)
Operator

Greetings. Welcome to the Pieris Pharmaceuticals Third Quarter 2019 Conference Call. (Operator Instructions) Please note, this conference is being recorded.

At this time, I'll turn the conference over to Tom Bures, Vice President of Finance. Sir, you may begin.

Thomas Bures
Pieris Pharmaceuticals, Inc. - Principal Financial & Accounting Officer and Treasurer

Good morning, everyone, and thank you for joining us for our third quarter 2019 conference call and corporate update. You can access the press release issued this morning on the Investor Relations page of our website at www.pieris.com.

Before we begin, I would like to caution that comments made during this conference call may contain forward-looking statements involving risks and uncertainties regarding the operations and future results of operations of Pieris, including statements related to the timing and progress of our clinical trials and preclinical programs, our partnerships and our financial position and actual

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot